Presentation Zeroes in on Successful CIN PYA, P.C.
Building a clinically integrated network (CIN) that brings together a hospital and community physicians, does not have to be a long, difficult process.
In a presentation given at the 2014 AHLA Physicians and Hospitals Law Institute, PYA Principal David McMillan, Flagler Hospital Chief Operating Officer Jason Barrett, and Smith Hulsey & Busey Attorney Shareholder Charmaine T. Chiu followed one healthcare community’s journey to form a CIN in nine months.
An Alternative to Traditional M&A: Hospital Network AlliancesPYA, P.C.
PYA Principal David McMillan presented during The Knowledge Congress webinar, “The Impact of Healthcare Reform in M&A,” which discussed the fundamentals and significant developments related to mergers and acquisitions (M&A) and healthcare reform and was designed to help healthcare executives and professionals avoid related, common pitfalls and risk issues. The webinar also explored hospital network alliances as an alternative to traditional M&A including.
Presentation Zeroes in on Successful CIN PYA, P.C.
Building a clinically integrated network (CIN) that brings together a hospital and community physicians, does not have to be a long, difficult process.
In a presentation given at the 2014 AHLA Physicians and Hospitals Law Institute, PYA Principal David McMillan, Flagler Hospital Chief Operating Officer Jason Barrett, and Smith Hulsey & Busey Attorney Shareholder Charmaine T. Chiu followed one healthcare community’s journey to form a CIN in nine months.
An Alternative to Traditional M&A: Hospital Network AlliancesPYA, P.C.
PYA Principal David McMillan presented during The Knowledge Congress webinar, “The Impact of Healthcare Reform in M&A,” which discussed the fundamentals and significant developments related to mergers and acquisitions (M&A) and healthcare reform and was designed to help healthcare executives and professionals avoid related, common pitfalls and risk issues. The webinar also explored hospital network alliances as an alternative to traditional M&A including.
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
How value based care is changing telehealth payment modelsVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/7AdJy2
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
Physician Payment Reforms: The Future of MIPS and APMs – Value-Based Payments...Epstein Becker Green
Epstein Becker Green Webinar with Attorney Lesley Yeung - Value-Based Payments Crash Course Webinar Series - May 16, 2016.
Topics include:
* An overview of the physician payment reforms included in the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”)
* A summary of the Merit-Based Incentive Payment System (“MIPS”) and Alternative Payment Models (“APMs”) Proposed Rule (publication is expected in the spring of 2016)
* Opportunities for provider engagement with the Centers for Medicare & Medicaid Services to shape physician payment reform efforts
http://www.ebglaw.com/events/physician-payment-reforms-the-future-of-mips-and-apms-value-based-payments-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Will the Revenue Ever Return? COVID-19 and the Rise of the Insurers; the Case...Health Catalyst
As healthcare providers face the long-term revenue compression of COVID-19, they’re also navigating significant industry changes. Current challenges include horizontal competition from large insurers and digital disrupters, growing telehealth volumes, headwinds from price transparency, and growth in managed care programs, like Medicare Advantage. Without restored or growing volumes, how do health systems return to profitability?
Health systems will need accurate financial data around service line and procedural profitability, which very few have. Allocations, estimates and averages of cost, and large pools of clinical “overhead” are inaccurate, and these methods have no credibility with physicians and administrators.
Join Rob DeMichiei, Strategic Advisor for Health Catalyst and former Executive Vice President and Chief Financial Officer for UPMC, to learn more.
What You’ll Learn:
- How insurers look at their medical expenses, and their plans to reduce utilization and steer volumes away from traditional providers.
- The implications of price transparency; why a rational pricing strategy is critical to success.
- Using existing EHR data to measure and assess 100 percent of your clinical costs.
- How improved costing enables service-line management and allows for improved clinical care delivery and insight into profitability.
- How activity-based costing can help identify physician and clinical variation.
- Implications of inaccurate RVU/RCC costing on contract negotiations, resource management, and productivity reporting.
- Benefits and simplicity of activity-based (consumption) costing.
MACRA: Restructuring Medicare ReimbursementPaul B. Tripp
Everyone must rethink their approach to the delivery of care. It is no longer a viable option to maintain the fee-for- service (FFS) mindset. New measures from CMS will push healthcare to the next level of reform where the patient is increasingly at the center of care and care payment.
Master Your Value-Based Care Strategy: Introducing Health Catalyst Value Opti...Health Catalyst
Each year CFOs and population health executives at health systems (and other risk-bearing entities) ask themselves: What is our strategy to realize maximum value in our risk-based contracts? Many organizations lack an approach for managing complex, risk-based populations—one that is driven by data, helps them understand their performance, and shows them which of their many options should be prioritized and pursued.
The Health Catalyst Value Optimizer™ solution help systems master their value-based care (VBC) strategy and achieve profitability in population health management. Delivering data aggregation, integration, and analysis, Value Optimizer instantly identifies the most valuable benchmarked opportunities for improvement across the continuum—offering actionable guidance for success in risk-based contracts.
Join Mike McBride, Vice President of Payment Transformation at Health Catalyst, as he demonstrates how Value Optimizer empowers leaders to confidently pursue a rational course toward improved risk-based performance.
What You’ll Learn about Value Optimizer:
• Comprehensive, quantified intelligence. Value Optimizer presents one solution to understand all your financial options—up to 10,000 possible opportunities across the care continuum—benchmarked and compared with dollar impact.
• Accuracy and context for better decisions. With continually refreshed data and benchmarking (using risk-adjusted codes, published research, or “digital twin” population matching), the app serves up timely and meaningful data to guide your VBC strategy.
• Transparency, not "black box." With fully disclosed and legible groupers, metric calculations, and risk and benchmarking methodologies, the solution allows open-book analytics across 10+ domains from inpatient to post-acute, prescriptions to coding, chronic to end-of-life care, etc.
• Expert guidance. Our most successful clients work with our services team to explore opportunities within the complete clinical, operational, and financial context for a given population—accessing guidance that up-levels their strategic insight and accelerates success.
Medicare Shared Savings Program--Foundation for a Clinically Integrated NetworkPYA, P.C.
Call them what you will—accountable care organizations, clinically integrated networks, community care organizations—collaborative efforts between independent providers are cropping up to address the challenges created by new payment and delivery models. Already faced with disparities in healthcare not found in urban areas, rural providers must develop new affiliation strategies to overcome these obstacles.
PYA Principal Martie Ross, in partnership with the National Rural Health Association, conducted a Rural Accountable Care Organizations webinar, "Medicare Shared Savings Program--Foundation for a Clinically Integrated Network."
Accountable Care Organizations (ACOs) and clinically integrated networks (CINs) are two types of organizations working to address the problem of rising costs. As ACOs and CINs continue to evolve, organizations moving into value-based care (VBC) face an ever-changing landscape. This article looks at the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. It also explores what healthcare experts believe the future of alternative payment models will look like and competencies to develop to meet those changing demands.
In January 2013, Catholic Health Initiatives began a multi-phase journey to develop a population health management solution across all of its regions. This presentation will describe the strategies the health system pursued for: creating a clinically integrated network as a first step in managing the health of populations and integrating care across the patient experience; aligning hospitals and physician groups to create successful clinical models; creating a data platform to share clinical measures and benchmarks; and ultimately becoming a risk-bearing shared savings ACO. Participants will hear real-world examples of best practices for how to meet FTC regulations, create an effective governance structure to manage performance, and align financial incentives. Learn how one of the nation's largest hospital systems developed a system-wide population health management solution in order to achieve the necessary transformation from fee-for-service to fee-for-value.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
The transformation towards more integrated and accountable healthcare delivery systems is aligning physicians, outpatient care, hospitals and ultimately payers in unprecedented numbers. Yet creating a successful clinically integrated network can be a daunting and complicated undertaking.
Yale New Haven Health System (YNHHS), a nonprofit academic medical center, is following a seven-phase plan to achieve a regional, clinically integrated network with the ultimate goal of population health management.
Conifer Health President of Value-Based Care, Megan North and Gayle Capozzalo, FACHE Executive Vice President/Chief Strategy Officer, Yale New Haven Health System (YNHHS), co-presented at the the Becker’s Hospital Review 7th Annual Meeting in Chicago. North and Capozzalo shared “A Seven-Step Approach to a Clinically Integrated Network,” to provide insights into each step of the clinical integration road map.
The Biggest Healthcare Trends of 2019 and What's to Come in 2020Health Catalyst
In our Healthcare Outlook for 2019 webinar, Stephen Grossbart, PhD, and Bobbi Brown, MBA, shared their predictions for the biggest trends of the year. Which predictions panned out and which didn’t? View this webinar as Stephen takes a look back at 2019 and makes his forecast for 2020.
So, what did happen in 2019? Following the 2018 midterm elections, we predicted a divided Congress would not pass policies to strengthen or weaken the Affordable Care Act (ACA). We were right. Meanwhile, Democratic presidential candidates debated the extent to which they would support Medicare for All. Insurance costs continued to rise, breaking $20,000 annually for families with employer-sponsored coverage, and CMS continued to support payment policies rewarding quality and interoperability as part of their payment policy.
Join Stephen as he looks in the rearview mirror at these important issues and how they impacted the healthcare industry in 2019 and then gazes into the crystal ball to predict the trends that will most impact healthcare in 2020. In this webinar, Stephen discusses the following topics and more:
• The continued focus on price transparency.
• Congress’ efforts to control prescription drug costs.
• Policies that may change the future of ACOs.
• What to expect going into the 2020 election year.
Learn about 2016 trends in government and private healthcare spending, employer costs, and the patient-as-consumer movement that's spurring new provider models.
How value based care is changing telehealth payment modelsVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/7AdJy2
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
Physician Payment Reforms: The Future of MIPS and APMs – Value-Based Payments...Epstein Becker Green
Epstein Becker Green Webinar with Attorney Lesley Yeung - Value-Based Payments Crash Course Webinar Series - May 16, 2016.
Topics include:
* An overview of the physician payment reforms included in the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”)
* A summary of the Merit-Based Incentive Payment System (“MIPS”) and Alternative Payment Models (“APMs”) Proposed Rule (publication is expected in the spring of 2016)
* Opportunities for provider engagement with the Centers for Medicare & Medicaid Services to shape physician payment reform efforts
http://www.ebglaw.com/events/physician-payment-reforms-the-future-of-mips-and-apms-value-based-payments-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Will the Revenue Ever Return? COVID-19 and the Rise of the Insurers; the Case...Health Catalyst
As healthcare providers face the long-term revenue compression of COVID-19, they’re also navigating significant industry changes. Current challenges include horizontal competition from large insurers and digital disrupters, growing telehealth volumes, headwinds from price transparency, and growth in managed care programs, like Medicare Advantage. Without restored or growing volumes, how do health systems return to profitability?
Health systems will need accurate financial data around service line and procedural profitability, which very few have. Allocations, estimates and averages of cost, and large pools of clinical “overhead” are inaccurate, and these methods have no credibility with physicians and administrators.
Join Rob DeMichiei, Strategic Advisor for Health Catalyst and former Executive Vice President and Chief Financial Officer for UPMC, to learn more.
What You’ll Learn:
- How insurers look at their medical expenses, and their plans to reduce utilization and steer volumes away from traditional providers.
- The implications of price transparency; why a rational pricing strategy is critical to success.
- Using existing EHR data to measure and assess 100 percent of your clinical costs.
- How improved costing enables service-line management and allows for improved clinical care delivery and insight into profitability.
- How activity-based costing can help identify physician and clinical variation.
- Implications of inaccurate RVU/RCC costing on contract negotiations, resource management, and productivity reporting.
- Benefits and simplicity of activity-based (consumption) costing.
MACRA: Restructuring Medicare ReimbursementPaul B. Tripp
Everyone must rethink their approach to the delivery of care. It is no longer a viable option to maintain the fee-for- service (FFS) mindset. New measures from CMS will push healthcare to the next level of reform where the patient is increasingly at the center of care and care payment.
Master Your Value-Based Care Strategy: Introducing Health Catalyst Value Opti...Health Catalyst
Each year CFOs and population health executives at health systems (and other risk-bearing entities) ask themselves: What is our strategy to realize maximum value in our risk-based contracts? Many organizations lack an approach for managing complex, risk-based populations—one that is driven by data, helps them understand their performance, and shows them which of their many options should be prioritized and pursued.
The Health Catalyst Value Optimizer™ solution help systems master their value-based care (VBC) strategy and achieve profitability in population health management. Delivering data aggregation, integration, and analysis, Value Optimizer instantly identifies the most valuable benchmarked opportunities for improvement across the continuum—offering actionable guidance for success in risk-based contracts.
Join Mike McBride, Vice President of Payment Transformation at Health Catalyst, as he demonstrates how Value Optimizer empowers leaders to confidently pursue a rational course toward improved risk-based performance.
What You’ll Learn about Value Optimizer:
• Comprehensive, quantified intelligence. Value Optimizer presents one solution to understand all your financial options—up to 10,000 possible opportunities across the care continuum—benchmarked and compared with dollar impact.
• Accuracy and context for better decisions. With continually refreshed data and benchmarking (using risk-adjusted codes, published research, or “digital twin” population matching), the app serves up timely and meaningful data to guide your VBC strategy.
• Transparency, not "black box." With fully disclosed and legible groupers, metric calculations, and risk and benchmarking methodologies, the solution allows open-book analytics across 10+ domains from inpatient to post-acute, prescriptions to coding, chronic to end-of-life care, etc.
• Expert guidance. Our most successful clients work with our services team to explore opportunities within the complete clinical, operational, and financial context for a given population—accessing guidance that up-levels their strategic insight and accelerates success.
Medicare Shared Savings Program--Foundation for a Clinically Integrated NetworkPYA, P.C.
Call them what you will—accountable care organizations, clinically integrated networks, community care organizations—collaborative efforts between independent providers are cropping up to address the challenges created by new payment and delivery models. Already faced with disparities in healthcare not found in urban areas, rural providers must develop new affiliation strategies to overcome these obstacles.
PYA Principal Martie Ross, in partnership with the National Rural Health Association, conducted a Rural Accountable Care Organizations webinar, "Medicare Shared Savings Program--Foundation for a Clinically Integrated Network."
Accountable Care Organizations (ACOs) and clinically integrated networks (CINs) are two types of organizations working to address the problem of rising costs. As ACOs and CINs continue to evolve, organizations moving into value-based care (VBC) face an ever-changing landscape. This article looks at the evolution of the ACO and CIN models, what new tools ACOs employ today to promote success, and lessons learned from organizations that have succeeded in alternative payment models. It also explores what healthcare experts believe the future of alternative payment models will look like and competencies to develop to meet those changing demands.
In January 2013, Catholic Health Initiatives began a multi-phase journey to develop a population health management solution across all of its regions. This presentation will describe the strategies the health system pursued for: creating a clinically integrated network as a first step in managing the health of populations and integrating care across the patient experience; aligning hospitals and physician groups to create successful clinical models; creating a data platform to share clinical measures and benchmarks; and ultimately becoming a risk-bearing shared savings ACO. Participants will hear real-world examples of best practices for how to meet FTC regulations, create an effective governance structure to manage performance, and align financial incentives. Learn how one of the nation's largest hospital systems developed a system-wide population health management solution in order to achieve the necessary transformation from fee-for-service to fee-for-value.
2021 Healthcare Trends: Embracing an Unpredictable FutureHealth Catalyst
We’re putting 2020 in the rearview mirror and gazing into the crystal ball to see what 2021 holds. Stephen Grossbart, PhD, and Dan Orenstein, JD, tackle the challenge of predicting what’s next for healthcare in 2021. Stephen and Dan discuss the trends and policies most impactful to the industry and attempt to answer the following questions on everyone’s mind.
- Healthcare technology—Where is it headed? What’s the next big thing?
- Care delivery—How will COVID-19 continue to impact healthcare systems, physicians, and patients? What changes will the industry make to prepare for future pandemics? What will happen with value-based care?
- The new Biden administration—What changes will it make that will impact healthcare? What will the Supreme Court/Congress do about the ACA?
The transformation towards more integrated and accountable healthcare delivery systems is aligning physicians, outpatient care, hospitals and ultimately payers in unprecedented numbers. Yet creating a successful clinically integrated network can be a daunting and complicated undertaking.
Yale New Haven Health System (YNHHS), a nonprofit academic medical center, is following a seven-phase plan to achieve a regional, clinically integrated network with the ultimate goal of population health management.
Conifer Health President of Value-Based Care, Megan North and Gayle Capozzalo, FACHE Executive Vice President/Chief Strategy Officer, Yale New Haven Health System (YNHHS), co-presented at the the Becker’s Hospital Review 7th Annual Meeting in Chicago. North and Capozzalo shared “A Seven-Step Approach to a Clinically Integrated Network,” to provide insights into each step of the clinical integration road map.
The FMBHP is a collaboration among frontier/rural healthcare communities; Mineral Community Hospital’s Interdisciplinary Medical Education Center; iVantage, an industry leader providing comprehensive hospital evaluation tools; Mayo Clinic’s Practice-Based Research Network (PBRN); and the Appalachian Osteopathic Postgraduate Training Institute Consortium (A-OPTIC). The FMBHP will partner with CMS, IHS, Veteran Administration and other private insurers to develop a seamless and sustainable model of patient-centered and community-based healthcare that produces better outcomes cost-effectively.
Population Health Management: Enabling Accountable Care in Collaborative Prov...Salus One Ed
This document provides the reader information about population health management (PMH), how it relates to incentive payments for healthcare providers and their health insurance partners (commercial and government). See details about required transformation of care delivery methods, typical accountable care payment models, how to achieve incentives, partnerships between state government (public health) and community shared services needs and necessary technology and data to achieve it.
The 10th Annual Utah Health Services Research Conference: Data: What's available and how we are use it is changing. By: Danielle A. Lloyd, MPH - Premier
Health Services Research Conference: March 16, 2015
Patient Centered Research Methods Core, University of Utah, CCTS
White Paper - Building Your ACO and Healthcare IT’s RoleNextGen Healthcare
The tools needed to capture, organize, and share healthcare data are truly evolving at the speed of light. Patient Centered Medical Homes play a vital role in the path toward accountable care and technology, staff, and workflow transformation are necessary to achieve PCMH recognition. This transformation allows healthcare providers to deliver higher quality coordinated care by streamlining and rationalizing the patient experience.
The Center for Medicare & Medicaid Services hosted a webinar on Thursday, April 14, 2016. During this webinar staff provided an overview of the model. A repeat of the webinar was held on Tuesday, April 19.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Similar to MeHI eQuality Incentive ProgramSolicitation No. 2015-MeHI-01 Question & Answer Webinar - November 12, 2014 (20)
MeHI Privacy & Security Webinar 3.18.15MassEHealth
Top Reason Why Providers Fail Meaningful Use Audits: Inadequate Security Risk Analysis
Providers are losing incentive dollars by not meeting the Meaningful Use Privacy & Security Measure.
Get on track with your Security Risk Assessment and attest to Meaningful Use with MeHI’s support & solutions:
• Assess your practice’s privacy and security status
• Develop remediation plans to resolve gaps
• Communicate resolution steps to the providers involved
• Track progress in addressing outstanding issues
Let us help you conduct a security risk analysis and address deficiencies and potential threats and ensure that your practice is compliant and that patient data is safe-guarded.
MeHI Mass HIway: Quick Guide to Using WebmailMassEHealth
The Mass HIway is the state's health information exchange which enables healthcare providers to send and receive information securely. If a provider practice has not yet implemented an EHR or is waiting on an EHR interface configuration they may choose webmail to connect to the Mass HIway. Webmail is a connection type option that allows providers to communicate via the Mass HIway through.
Meaningful Use Stage 2 and Health Information Exchange (HIE)MassEHealth
Transformational intent of Meaningful Use (MU) and the increased trend toward interoperability in MU Stage 2 (MU2); MU2 objectives with an HIE component and their MU2 measures; Approaches to achieving the transitions of care; Available public health registries and their current status and submission pathway; How to find a trading partner and best practices to engaging
MeHI Regional Health IT Meetings - Worcester, MA - Nov, 2013MassEHealth
Presentation from the Massachusetts eHealth Institute Regional Health IT meeting in Worcester, MA in November, 2013. Featuring Larry Garber from Reliant Medical Group.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
8. MeHI is the designated
state agency for:
Coordinating health care
innovation, technology and
competitiveness
Accelerating the adoption of
health information technologies
Promoting health IT to improve
the safety, quality and efficiency
of health care in Massachusetts
Advancing the dissemination of
electronic health records
systems in all health care
provider settings
MBI
MASSACHUSETTS
BROADBAND INSTITUTE
MeHI is a division of the Massachusetts
Technology Collaborative, a public
economic development agency
8
MeHI Overview
THE INNOVATION INSTITUTE
at the MassTech Collaborative
MeHI
MASSACHUSETTS
eHEALTH INSTITUTE
• Tech Hub Collaborative
• Big Data Consortium
• Advanced Manufacturing
Collaborative
• Innovation Index
• Mass Broadband 123
• MassVetsAdvisor
• Interoperable EHR Adoption
• Connected Communities
• eHealth Services & Support
• eHealth Cluster
Massachusetts eHealth Institute
16. 16
eQIP | Detailed Eligibility Criteria
Eligibility Criteria Method of Substantiation*
1.
Provide BH clinical care services in MA Statement of Operations/Income Statement
indicating Patient Service Revenue* (PSR)
for any month (6/1/14 through 9/30/14)
2.
Hold license to provide BH clinical care
programs/services in MA, OR
Its providers have valid professional
licenses
Currently valid license(s) to provide BH
clinical care programs/services (by DPH) or
MA DMH certification as provider of BH
services
3.
Provide primarily BH services
(>50% of annual PSR from BH
services in MA)
Documentation indicating
(1) Percent of PSR for last SFY and
(2) Source/amount for all BH PSR (private
payer(s), Medicaid, Medicare etc.)
4.
Is a not-for-profit corporation Certificate of Good Standing for a not-for-profit
corporation in MA
** Patient Services Revenue = NPSR (3rd party payers) + revenue under a state or local
contract to provide BH services
17. 17
eQIP | Detailed Eligibility Criteria (cont.)
Eligibility Criteria Method of Substantiation
5.
No financial relationship/affiliation to a
health care system
Corporate org chart showing ownership,
governance & operational structure
5A.
Organizations that are part of a
system meet this criteria . . . IF:
Annual PSR of parent org is <$25M
Documentation: annual PSR of parent org
is <$25M
6.
Serve large proportion of public payer
clients
(>50% of PSR is public payer )
Documentation: portion of PSR from public
payer for last SFY
7.
Not an Eligible Hospital (“EH”) and
providers are not Eligible Professionals
(“EPs”)
Documentation: is not an EH and its
providers are not EPs
7B.
Organizations that have some EPs
meet this criteria . . . IF:
Number of EPs >30% of clinical staff,
and
Is either independent or annual PSR
of parent org is <$25M
Documentation: total clinical staff &
percent of EPs AND
Documentation: no financial
relationship/affiliation or annual PSR of
parent org is <$25M
22. 22
eQIP | Milestones
Milestone 1 (15% of total incentive) = required EMRAM* Stage 1 & 2
– Desktop access to clinical information, unstructured data, multiple data sources,
intra-office/informal messaging
– Beginning of a CDR with orders and results, computers may be at point-of-care,
access to results from outside facilities
Milestone 2 (25% of total incentive) = required EMRAM* Stage 3
– Electronic messaging, computers have replaced the paper chart, clinical
documentation and clinical decision support
Milestone 3 (35% of total incentive) = required EMRAM* Stage 4 & 5
– Computerized Provider Order Entry, Use of structured data for accessibility in
EMR and internal and external sharing of data
– Personal health record, online tethered patient portal
________________________
HIway Milestone 4 (25% of total incentive) = Transacting on Mass HIway
– “Floating” Milestone
– Organizations can meet the HIway Milestone at any time after meeting M-1
– Must be integrated into the EHR
*NOTE: some requirements may not be applicable to BH organizations
23. eQIP: A-EMRAM Stages – overview
23
HIMSS Ambulatory EMR Adoption Model (A-EMRAM)
̶ Focus on key IT systems that need to be implemented for achieving higher levels of access,
quality, efficiency and safety
US Ambulatory EMR Adoption Model SM
eQIP
Milestone
Stage Cumulative Capabilities
Stage 7 HIE capable, sharing of data between the EMR and community based EHR, business
and clinical intelligence
Stage 6 Advanced clinical decision support, proactive care management, structured messaging
M-3
Stage 5 Personal health record, online tethered patient portal
Stage 4 CPOE, Use of structured data for accessibility in EMR and internal and
external sharing of data
M-2
Stage 3 Electronic messaging, computers have replaced the paper chart, clinical
documentation and clinical decision support
M-1
Stage 2 Beginning of a CDR with orders and results, computers may be at point-of-care,
access to results from outside facilities
Stage 1 Desktop access to clinical information, unstructured data, multiple data
sources, intra-office/informal messaging
Stage 0 Paper chart based